The COBRA Surgical System
All COBRA products feature Estech’s patented temperature controlled radio-frequency (RF) technology. Temperature control provides a meaningful endpoint, maintaining tissue at safe yet effective temperatures to produce the desired lesion set. Internal probe cooling and advanced suction help to ensure reproducible transmural (full-thickness) endocardial or epicardial lesions. Versatile design enables the surgeon to use COBRA for minimally invasive or traditional procedures for either standalone or concomitant with valve or CABG surgery.
Instructions For Use
- COBRA Fusion™ 150
- COBRA Fusion™ 50
- COBRA Adhere XL™ Surgical System
- COBRA Adhere XL™ Surgical System with Integrated Cable
- COBRA Cooled™ Surgical Probe
- COBRA Cooled™ Surgical Probe with Integrated Cable
- COBRA® Surgical Probe
- COBRA® Surgical Probe with Integrated Cable
- COBRA® Revolution Bipolar Clamp
- COBRA® Electrosurgical Unit (ESU)
- COBRA AFfirm™ Bipolar Pacing Probe
- COBRA® Magnetic Introducer
- COBRA® Cable
COBRA Revolution™ Bipolar Clamp
COBRA Revolution is the newest member of the Estech family of ablation products. The Revolution offers the industry’s first reversible jaws allowing both right and left curve capabilities in one clamp. It is fully disposable and provides the clinical benefit of deep transmural lesion formation combined with unsurpassed ergonomics for ease of use. Additionally, this new state of the art technology features the safety and effectiveness that only Estech’s temperature controlled technology can provide.
In the U.S., the Estech COBRA Revolution and COBRA Bipolar Inserts have been cleared for ablation of soft tissues. The COBRA Adhere XL, COBRA Cooled and COBRA Surgical probes have been cleared for cardiac ablation. The AFfirm Pacing Probe has been cleared to be used upon completion of cardiac ablation procedures to assess the adequacy of cardiac lesions created in surgically treating the patient’s arrhythmia. Estech does not promote off-label use of its products and their use is at the discretion of the cardiac surgeon. Estech is undertaking an Investigational Device Exemption (IDE) clinical trial and subsequent Premarket Approval Application (PMA) submission in the U.S. to obtain a specific atrial fibrillation indication. In Europe, the Estech COBRA RF ablation products are CE marked with an indication for the treatment of atrial fibrillation by ablating cardiac tissue during surgery.
|600-008i||COBRA Revolution™ Bipolar Clamp|